Overview

Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic Surgery

Status:
Terminated
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the analgesic efficacy and safety of N1539 in subjects undergoing abdominal laparoscopic surgery.
Phase:
Phase 3
Details
Lead Sponsor:
Alkermes, Inc.
Treatments:
Ketorolac
Ketorolac Tromethamine